Literature DB >> 15573409

Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor.

Feng-Yan Sun1, Xin Guo.   

Abstract

The present view of the neuroprotective functions and mechanisms of action of vascular endothelial growth factor (VEGF) is based on studies of neuronal ischemic/hypoxic models in vivo and in vitro. Endogenous neuronal VEGF increases in the ischemic brain and plays a neuroprotective role in the pathophysiologic processes that follow stroke. Exogenous VEGF, directly administered or overexpressed by gene delivery into rat brains, reduces ischemic brain infarct and decreases hypoxic neuronal death. The main neuroprotective mechanisms of VEGF include: (1) modulation of the phosphatidylinositol 3'-kinase (PI3K)/Akt/nuclear factor-kappaB signaling pathway, inhibition of caspase-3 activity, and reduction of ischemic neuronal apoptosis; (2) inhibition of outward delayed rectifier potassium channel currents and increase of ischemia-induced tyrosine phosphorylation of Kv1.2 potassium channel proteins via activation of the PI3K pathway; and (3) enhancement of proliferation and migration of neural progenitors in the subventricular zone and improvement of striatal neurogenesis and maturation of newborn neurons in adult rat brains after stroke. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15573409     DOI: 10.1002/jnr.20321

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  41 in total

1.  Vascular endothelial growth factor protects post-ganglionic sympathetic neurones from the detrimental effects of hydrogen peroxide by increasing catalase.

Authors:  D H Damon
Journal:  Acta Physiol (Oxf)       Date:  2011-03-14       Impact factor: 6.311

2.  Evolution of the VEGF-regulated vascular network from a neural guidance system.

Authors:  Sreenivasan Ponnambalam; Mario Alberghina
Journal:  Mol Neurobiol       Date:  2011-01-28       Impact factor: 5.590

3.  VEGF as a target for neuroprotection.

Authors:  Annamaria Vezzani
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

Review 4.  Neurorestorative treatment of stroke: cell and pharmacological approaches.

Authors:  Jieli Chen; Michael Chopp
Journal:  NeuroRx       Date:  2006-10

5.  Ginsenoside Rd promotes neurogenesis in rat brain after transient focal cerebral ischemia via activation of PI3K/Akt pathway.

Authors:  Xin-yu Liu; Xin-yu Zhou; Jin-cai Hou; Hua Zhu; Zhong Wang; Jian-xun Liu; Yong-qiu Zheng
Journal:  Acta Pharmacol Sin       Date:  2015-03-16       Impact factor: 6.150

6.  Neuroprotective effect of Crocus sativus against cerebral ischemia in rats.

Authors:  Rehab F Abdel-Rahman; Sally A El Awdan; Rehab R Hegazy; Dina F Mansour; H A Ogaly; Marwan Abdelbaset
Journal:  Metab Brain Dis       Date:  2019-11-14       Impact factor: 3.584

7.  CX3CR1-Mediated Akt1 Activation Contributes to the Paclitaxel-Induced Painful Peripheral Neuropathy in Rats.

Authors:  Dai Li; Hui Chen; Xiao-Huan Luo; Yang Sun; Wei Xia; Yuan-Chang Xiong
Journal:  Neurochem Res       Date:  2016-03-09       Impact factor: 3.996

8.  Increased protein and mRNA expression of endostatin in the ischemic brain tissue of rabbits after middle cerebral artery occlusion.

Authors:  Heng-Li Tian; Hao Chen; Yu-Hui Cui; Tao Xu; Liang-Fu Zhou
Journal:  Neurosci Bull       Date:  2007-01       Impact factor: 5.203

9.  Vascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampus.

Authors:  J N Nicoletti; S K Shah; D P McCloskey; J H Goodman; A Elkady; H Atassi; D Hylton; J S Rudge; H E Scharfman; S D Croll
Journal:  Neuroscience       Date:  2007-10-26       Impact factor: 3.590

Review 10.  VEGF as a potential target for therapeutic intervention in depression.

Authors:  Jennifer L Warner-Schmidt; Ronald S Duman
Journal:  Curr Opin Pharmacol       Date:  2007-12-03       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.